◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

CELLDEX THERAPEUTICS, INC.

CIK: 744218 SIC: 2835
$2.97M
Revenue
$-258.76M
Net Income
-
Gross Margin
-9675.62%
Op. Margin
$-367.67M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 14 of 44 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $121.00K $1.42M $730.00K $695.00K $1.18M $3.19M $2.50M $156.00K $4.13M $1.52M $268.00K $967.00K $1.61M $407.00K
Revenue Growth % (YoY) -89.7% -55.4% -70.8% 345.5% -71.6% 110.3% 832.1% -83.9% 156.1% 272.7% nan% nan% nan% nan%
Operating Expenses $87.27M $73.62M $64.59M $63.43M $57.20M $55.32M $48.81M $40.76M $51.76M $42.76M $33.47M $33.44M $29.50M $28.10M
Research & Development $75.33M $62.93M $54.20M $52.61M $46.94M $45.26M $39.69M $31.66M $30.43M $34.53M $26.25M $26.80M $22.90M $21.57M
+ Operating Income $-87.15M $-73.62M $-63.86M $-62.74M $-56.03M $-52.13M $-46.32M $-40.61M $-47.63M $-41.24M $-33.20M $-32.47M $-27.89M $-27.70M
Operating Margin % -72027.3% -5169.7% -8747.5% -9027.2% -4768.3% -1633.5% -1854.2% -26030.8% -1152.9% -2718.5% -12389.9% -3357.9% -1728.8% -6804.9%
Income Before Tax - - - - - - - - - - - - $-26.49M $-26.78M
+ Net Income $-81.32M $-67.04M $-56.60M $-53.80M $-47.09M $-42.12M $-35.84M $-32.81M $-43.31M $-38.26M $-30.50M $-29.36M $-26.49M $-26.78M
Net Margin % -67204.1% -4708.1% -7753.4% -7740.4% -4007.8% -1320.0% -1434.8% -21030.8% -1048.3% -2522.1% -11381.3% -3036.3% -1642.1% -6580.8%
Basic EPS -1.23 -1.01 -0.85 -0.81 -0.71 -0.64 -0.54 -0.56 -0.84 -0.81 -0.65 -0.62 -0.57 -0.57
Diluted EPS -1.23 -1.01 -0.85 -0.81 -0.71 -0.64 -0.54 -0.56 -0.84 -0.81 -0.65 -0.62 -0.57 -0.57
Basic Shares Outstanding - 66K 66K 66K 658 66K 66K 59K 1K 47K 47K 47K -46.8M 46.9M
Diluted Shares Outstanding - 66K 66K 66K 658 66K 66K 59K 1K 47K 47K 47K -46.8M 46.9M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $28.87M $36.04M $23.04M $17.14M $28.36M $36.40M $42.74M $115.08M $34.81M $21.13M $28.22M $54.12M $29.43M $18.58M
Short-term Investments $489.70M $547.19M $607.29M $656.15M $696.92M $719.60M $759.58M $708.77M $388.78M $214.21M $224.47M $224.26M $275.52M $304.89M
Other Current Assets $14.08M $21.03M $17.98M $19.40M $21.18M $21.99M $8.12M $8.81M $5.47M $10.33M $12.01M $9.90M $12.39M $10.94M
Total Current Assets $534.66M $604.34M $648.40M $693.76M $747.16M $778.84M $811.98M $835.32M $431.69M $245.93M $264.82M $289.60M $317.69M $334.60M
Property Plant & Equipment $5.33M $4.83M $4.39M $4.60M $4.35M $4.23M $3.86M $4.06M $4.06M $4.16M $3.94M $4.00M $3.75M $3.75M
Intangible Assets $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M $27.19M
Other Non-current Assets $13.36M $9.36M $9.30M $10.41M $9.75M $9.75M $107.00K $107.00K $107.00K $107.00K $107.00K $104.00K $104.00K $104.00K
Total Assets $582.98M $648.44M $692.41M $739.47M $792.34M $823.18M $845.59M $868.85M $465.63M $280.26M $299.31M $324.52M $352.74M $369.23M
Accounts Payable $1.18M $4.27M $2.07M $3.41M $3.27M $1.11M $3.80M $3.23M $3.49M $3.59M $881.00K $3.37M $3.34M $2.27M
Accrued Liabilities $47.03M $39.72M $28.42M $25.46M $33.84M $28.20M $18.59M $17.54M $22.03M $18.47M $12.26M $9.37M $12.84M $11.43M
Other Current Liabilities $1.23M $930.00K $930.00K $1.65M $942.00K $1.40M $3.67M $3.88M $3.99M $4.23M $978.00K $978.00K $990.00K $1.15M
Total Current Liabilities $50.99M $46.47M $32.96M $32.02M $39.50M $32.09M $27.66M $26.29M $31.12M $27.84M $15.65M $15.22M $18.61M $16.29M
Other Non-current Liabilities $4.04M $2.54M $2.54M $2.54M $3.47M $3.47M $3.47M $3.47M $4.40M $4.40M $4.40M $4.40M $5.33M $5.33M
Total Liabilities $55.82M $50.08M $37.00M $36.49M $45.34M $37.27M $31.93M $30.23M $36.46M $33.54M $21.77M $21.78M $26.53M $23.81M
Common Stock $67.00K $66.00K $66.00K $66.00K $66.00K $66.00K $66.00K $66.00K $56.00K $47.00K $47.00K $47.00K $47.00K $47.00K
Retained Earnings $-1.81B $-1.73B $-1.67B $-1.61B $-1.56B $-1.51B $-1.47B $-1.43B $-1.40B $-1.35B $-1.32B $-1.29B $-1.26B $-1.23B
Total Stockholders Equity $527.16M $598.36M $655.41M $702.98M $747.00M $785.90M $813.66M $838.61M $429.17M $246.72M $277.54M $302.74M $326.20M $345.42M
Total Liabilities & Equity $582.98M $648.44M $692.41M $739.47M $792.34M $823.18M $845.59M $868.85M $465.63M $280.26M $299.31M $324.52M $352.74M $369.23M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-81.32M $-67.04M $-56.60M - $-47.09M - - - $-43.31M - - - - -
Depreciation & Amortization $816.00K $2.56M $1.74M $867.00K $819.00K $2.36M $1.57M $775.00K $759.00K $2.25M $1.48M $726.00K $673.00K $2.22M
Stock-based Compensation $8.91M $27.31M $18.51M $9.32M $9.78M $24.46M $14.84M $7.20M $7.21M $16.68M $9.56M $4.34M $4.51M $11.10M
Operating Cash Flow $-63.94M $-147.00M $-98.38M $-54.37M $-32.48M $-125.30M $-69.97M $-40.64M $-32.53M $-74.76M $-55.77M $-28.57M $-21.76M $-81.97M
Capital Expenditure $1.28M $1.43M $993.00K $265.00K $756.00K $1.16M $618.00K $344.00K $666.00K $1.15M $995.00K $585.00K $235.00K $1.59M
Purchases of Investments $54.79M $329.71M $274.08M $151.82M $129.18M $660.75M $560.69M $392.18M $241.39M $183.17M $155.42M $73.85M $56.35M $132.61M
Investing Cash Flow $55.42M $153.65M $92.80M $42.95M $24.05M $-314.18M $-361.93M $-315.21M $-171.16M $65.38M $53.73M $52.57M $31.21M $58.73M
Stock Issued - - - - - $432.30M $432.30M $432.30M - - - - - -
Financing Cash Flow $1.35M $1.04M $265.00K $202.00K $386.00K $441.06M $439.82M $436.11M $217.37M $1.08M $827.00K $694.00K $1.40M $2.68M
Net Change in Cash $-7.17M $7.68M $-5.31M $-11.22M $-8.04M $1.58M $7.92M $80.26M $13.68M $-8.29M $-1.21M $24.69M $10.85M $-20.56M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - $1.42M -
Operating Expenses $73.62M - $201.64M -
Research & Development $62.93M - $169.74M -
Operating Income $-73.62M - $-200.21M -
Net Income $-67.04M $-35.84M $-177.44M -
Basic EPS -1.01 - -2.67 -
Diluted EPS -1.01 - -2.67 -
Basic Shares Outstanding $66.42K - $66.40K -
Diluted Shares Outstanding $66.42K - $66.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $36.04M $28.36M
Short-term Investments $547.19M $696.92M
Other Current Assets $21.03M $21.18M
Total Current Assets $604.34M $747.16M
Property Plant & Equipment $4.83M $4.35M
Intangible Assets $27.19M $27.19M
Other Non-current Assets $9.36M $9.75M
Total Assets $648.44M $792.34M
Accounts Payable $4.27M $3.27M
Accrued Liabilities $39.72M $33.84M
Other Current Liabilities $930.00K $942.00K
Total Current Liabilities $46.47M $39.50M
Other Non-current Liabilities $2.54M $3.47M
Total Liabilities $50.08M $45.34M
Common Stock $66.00K $66.00K
Retained Earnings $-1.73B $-1.56B
Total Stockholders Equity $598.36M $747.00M
Total Liabilities & Equity $648.44M $792.34M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-67.04M $-35.84M $-177.44M -
Depreciation & Amortization - - $2.56M -
Stock-based Compensation - - $27.31M -
Operating Cash Flow - - $-147.00M -
Capital Expenditure - - $1.43M -
Purchases of Investments - - $329.71M -
Investing Cash Flow - - $153.65M -
Financing Cash Flow - - $1.04M -
Net Change in Cash - - $7.68M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...